Organization · Family Office

Korify Capital

Korify Capital is a family office that invests in companies focused on longevity and mental health, targeting Series A to C funding rounds. They aim to support innovative teams and technologies in these sectors.

Family OfficeFunder

Overview

What Korify Capital does

What Korify Capital is

Korify Capital is a family office that invests in companies focused on longevity and mental health, targeting Series A to C funding rounds. They aim to support innovative teams and technologies in these sectors.

How it participates in the startup ecosystem

The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status
Active
Organization type
Family Office
Structured capabilities
Funder
Last reviewed
March 4, 2026

Official channels

Find Korify Capital elsewhere

Open the official website or a supported primary organization account.

Capability profile

Korify Capital as a funder

Investment thesis

Korify Capital's investment thesis centers on breakthrough technologies in longevity and mental health, targeting companies that have demonstrated strong traction and proof of concept.

Focus narrative

Korify Capital invests in companies that are in Series A to C funding rounds. The organization targets companies that have demonstrated strong traction and proof of concept, positioning them as future leaders in their respective fields.

Focus and fit

Stages
Series A · Series B · Series C

Availability

Currently deploying
Not published

Portfolio and track record

Recorded portfolio count
3

Portfolio context

Notable portfolio companies include: Alto Neuroscience: Focuses on psychiatric drug development using AI-derived brain biomarkers to match patients with promising treatments. Cambrian: Develops therapeutics aimed at extending healthspan, the period of life spent in good health. Refoxy: Works on therapeutic medicines targeting age-related diseases, specifically through FOXO modulators.

Connected ecosystem

Continue from Korify Capital

These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.

Common questions

What to know about Korify Capital

Upseed classifies Korify Capital under the Family Office organization type. Its current public profile includes funder capabilities.

Next step

Keep comparing startup organizations

Return to the organization index or continue through a verified sector, place, peer, or program connected to this profile.

Source and update disclosure

Know what this page is based on

Source basis

Public organization and program material, official websites, and structured Upseed records.

Last reviewed

March 4, 2026

Known limits

Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.

Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.